Lyka Labs · NSE: LYKALABS · BSE: 500259
Q4 FY24 results · Jan–Mar 2024
Lyka Labs reported revenue from operations of ₹27.77 crore (up 24.9% from Q4 FY23) and net loss of ₹2.14 crore for Q4 FY24 (Jan–Mar 2024), on a consolidated basis.
| Item | Q4 FY24 | Q4 FY23 | YoY | Q3 FY24 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 27.77 | 22.24 | +24.9% | 32.56 | −14.7% |
| Other income | 0.29 | 0.43 | −32.2% | 0.54 | −46.3% |
| Total income | 28.06 | 22.67 | +23.8% | 33.11 | −15.2% |
| Profit before tax | (1.68) | (3.00) | Loss narrowed | 3.29 | Turned loss |
| Net profit for the period | (2.14) | (3.00) | Loss narrowed | 2.01 | Turned loss |
| EPS, basic (₹) | (3.83) | (1.05) | Loss widened | 0.53 | Turned loss |
| Net margin (%) | -7.7 | -13.5 | 6.2 |
| Item | Q4 FY24 | Q4 FY23 | YoY | Q3 FY24 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 26.98 | 19.46 | +38.7% | 31.42 | −14.1% |
| Other income | 0.39 | 0.61 | −36.6% | 0.52 | −25.8% |
| Total income | 27.37 | 20.07 | +36.4% | 31.94 | −14.3% |
| Profit before tax | (1.21) | (2.93) | Loss narrowed | 2.40 | Turned loss |
| Net profit for the period | (1.62) | (3.01) | Loss narrowed | 1.36 | Turned loss |
| EPS, basic (₹) | (0.50) | (1.05) | Loss narrowed | 0.40 | Turned loss |
| Net margin (%) | -6.0 | -15.4 | 4.3 |
Consolidated
- Filed with BSE
- 12 Jun 2024, 17:50 IST
- Board meeting
- 21 May 2024
- Period
- 01 Jan 2024 to 31 Mar 2024
- Review status
- Audited
- Source
- XBRL filing on BSE
Standalone
- Filed with BSE
- 12 Jun 2024, 17:50 IST
- Board meeting
- 21 May 2024
- Period
- 01 Jan 2024 to 31 Mar 2024
- Review status
- Audited
- Source
- XBRL filing on BSE